Meet with… Texas Halo Fund

Add this event to your calendar:
15/11/2017 11:30 15/11/2017 14:00 America/Chicago Meet with… Texas Halo Fund JLABS @ TMC , John P. McGovern Campus , Houston , TX 77021 JLABS @ TMC false DD/MM/YYYY

Meet with… Texas Halo Fund

JLABS @ TMC , John P. McGovern Campus , Houston , TX 77021

November 15, 2017 from 11:30 AM to 14:00 PM (CST)

$10 - $35

On November 15th, The Texas Halo Fund will be in attendance to give an overview presentation about their company's key areas of interest and to meet 1-on-1 with companies that have been accepted after applying online.

The Fund is interested in early-stage companies, with principal operations in Texas.   A company must be organized as a corporation, and must raise at least $150,000 in committed capital from Angels from an organized group, in order to be eligible for consideration by the Fund.  The Fund invests in conjunction with a Texas-based Angel group, which are members of the Alliance of Texas Angel Networks.  Deals that do not meet these criteria will not be considered.

The Fund seeks deals which will achieve an internal rate of return for the Fund of 25 per cent or more, and will provide full liquidity for the Fund within eight years.


10:30am | Registration Opens and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
1:00-5:00pm | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on October 31st. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on November 14th (or sold out). 

Texas Halo Fund Participating Representatives:

David Steakley | Chairman, Houston Angel Network

David Steakley is an Angel investor in Houston.  Mr. Steakley serves on the Board of Directors of a number of his portfolio companies including HeatGenie, Pervino, Inc.,  Salient  Pharmaceuticals and Vendor Safe.  He is Chairman of the Houston Angel Network.  Previously, Mr. Steakley was a Partner at Accenture, serving clients in the financial services industry, for almost 20 years.  Mr Steakley studied Mathematics and American Studies at Williams College.

Robert Tucci | Board of Directors, Texas Halo Fund
Rob Tucci is an active investor and eight year member, board member, and Life Sciences Chair at the Houston Angel Network. He is a member of the University of Houston’s Cougar Fund, serving as a judge and has lectured in the Bauer School of Business. At the $6.5M Texas Halo Fund, Rob serves on the managing Board of Directors and directs investments generally within the biotechnology, life sciences and energy sectors. He is the founder (1996) of Yardley Group, LLC, an active chemical development and export business serving South America. Rob has served as a judge at the Rice University Business Plan Competition, the world’s largest. He is an investment adviser to the University of Texas Horizon Fund, the National Space Biomedical Research Institute, Molecular Match, Inc. and Houston Health Ventures, where he is also a founding member. Rob is also on the Board of Directors of Adient Medical, Inc. A chemist and MBA, Rob resides in Houston with his physician wife.


Presentation & Lunch
$25 | General Public
$35 | Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on November 13th (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies

Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on October 31st. Your application will be reviewed and you will be notified of acceptance by email. Acceptance of one-on-one meetings is not guaranteed as all applications must be approved.

About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, NCI, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCATS, NINDS, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.

John P. McGovern Campus
2450 Holcombe Blvd, Suite J
Houston, TX 77021

Parking Information:
Please park in the self parking areas of the McGovern Campus. Grab a Token at the gate and bring it to the event space. We encourage carpooling and using the TMC shuttles.


Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit

Event contact

Related content